Credicorp's Quiet Period Becomes the Only Certainty Before Thursday's Results

Credicorp Ltd. (BAP) reports first-quarter 2026 earnings after the close on Thursday, May 14, with analysts expecting $7.06 per share — a significant acceleration from the prior quarter's disappointing miss. The central question: can Peru's largest financial services company return to its growth trajectory after stumbling in Q4, or will macroeconomic headwinds and credit quality concerns continue to weigh on results?

Part 1: Earnings Preview

Credicorp Ltd. is Peru's leading financial services holding company, operating primarily through Banco de Crédito del Perú (BCP), with additional businesses in insurance, investment management, and microfinance across Latin America. The company serves as the dominant player in Peruvian banking and a bellwether for the region's economic health.

Credicorp is scheduled to report Q1 2026 results after the market close on Thursday, May 14, with a conference call set for Friday, May 15 at 10:30 AM ET. Analysts expect earnings of $7.06 per share on revenue of $1.81 billion for the quarter. The company most recently reported $5.88 per share for Q4 2025, missing estimates by 11.04% in a disappointing end to the year. The current estimate represents +17.28% growth compared to the $6.02 reported in Q1 2025, suggesting analysts anticipate a strong rebound.

Three key themes define this earnings story heading into the release:

Credit Quality and Loan Growth Dynamics: Investors will scrutinize whether Credicorp can maintain loan portfolio expansion while keeping non-performing loans in check. Peru's economic recovery trajectory and the bank's ability to balance growth with risk management remain critical factors, particularly after Q4's miss raised concerns about asset quality deterioration.

Net Interest Margin Pressure: With interest rate dynamics shifting across Latin America, the sustainability of Credicorp's net interest margins will be closely watched. The company's ability to defend spreads while competing for deposits in a challenging rate environment could determine whether the earnings acceleration is sustainable beyond Q1.

Regional Expansion and Diversification: Beyond Peru, Credicorp's performance in its insurance, wealth management, and microfinance segments will signal whether the company is successfully diversifying revenue streams and reducing concentration risk in its home market.

Analyst commentary ahead of the release reflects cautious optimism. UBS Group raised its price target from $318 to $408 with a Buy rating in April, citing improving fundamentals and regional growth prospects. However, the consensus remains mixed, with Goldman Sachs maintaining a Neutral stance at a $330 target, suggesting some analysts remain unconvinced that the Q4 stumble was merely a one-quarter aberration. The average price target of $346 implies meaningful upside from current levels, but the wide range between the low estimate of $219 and high of $412 underscores significant uncertainty about the company's near-term trajectory.

Part 2: Historical Earnings Performance

Credicorp's recent earnings track record shows a pattern of modest beats punctuated by occasional misses, with performance becoming more volatile over the past year. In the three most recent quarters with available data, the company delivered +8.90% and +1.98% surprises in Q2 and Q3 2025, respectively, before stumbling with an -11.04% miss in Q4 2025 — the largest negative surprise in the recent dataset.

Looking at the longer historical pattern, Credicorp demonstrated more consistent execution through 2024, with beats of +19.06% (Q1), -3.23% miss (Q2), +8.78% (Q3), and +14.89% (Q4). The 2025 performance trajectory — starting strong in mid-year before deteriorating in Q4 — suggests the company may be facing headwinds that intensified in the latter part of the year.

The magnitude of beats when they occur has been meaningful, often in the 5-10% range, but the Q4 2025 miss broke a string of positive surprises and raises questions about whether estimates for Q1 2026 have been appropriately recalibrated. The +17.28% year-over-year growth embedded in current estimates represents an optimistic view that the company can quickly reverse the Q4 disappointment.

Note: These figures reflect diluted GAAP earnings per share, reported before non-recurring items, and may differ from the non-GAAP figures used by some sources.

Part 2.1: Price Behavior Around Earnings

Credicorp reports after market close, meaning Day 0 captures anticipatory trading before results are released, while Day +1 represents the market's first full reaction to actual earnings.

Historical price behavior around Credicorp earnings reveals moderate volatility with an average absolute Day 0 move of 2.05% and Day +1 move of 1.57%, though individual reactions have varied widely. The most dramatic recent move came after the May 2025 report, when the stock dropped 6.31% on Day 0 in anticipation, followed by a +2.78% recovery on Day +1 — suggesting the market initially overreacted to concerns.

The November 2025 earnings triggered the second-largest reaction, with a 3.95% Day 0 decline followed by a muted +0.65% Day +1 move and an 11.81% intraday range, indicating significant uncertainty. More recently, the February 2026 report (reflecting Q4 2025's miss) produced a relatively contained 0.77% Day 0 decline and 3.30% Day +1 drop, with a 4.60% range — suggesting the market may have already priced in some disappointment.

The average Day +1 range of 5.38% indicates investors should prepare for meaningful volatility in Friday's session following Thursday's after-hours release, with historical precedent showing swings can exceed 10% in either direction when results significantly diverge from expectations.

Part 2.2: Options Market Expected Move

The options market is pricing a 4.08% expected move (±$13.01, range $305.40–$331.41) through the May 15 expiration, which is notably higher than the historical average Day +1 move of 1.57% but below the average Day +1 range of 5.38%. This suggests options traders are anticipating above-average volatility but not an extreme outlier reaction, positioning for a move roughly in line with the more volatile historical episodes like November 2025.

Part 3: What Analysts Are Saying

Analyst sentiment on Credicorp remains constructive but not overwhelmingly bullish, with a consensus rating of 4.33 out of 5 (between Buy and Strong Buy) based on 6 Strong Buy ratings, 0 Moderate Buy ratings, and 3 Hold ratings. Notably, there are no Sell or Strong Sell ratings among the 9 analysts covering the stock, indicating a floor of confidence in the company's long-term prospects despite near-term uncertainty.

The average price target of $346.00 implies +8.9% upside from the current price of $317.68, suggesting analysts see moderate appreciation potential over the next 12 months. However, the wide dispersion in targets — ranging from a low of $219.00 to a high of $412.00 — reflects significant disagreement about valuation and growth trajectory. The high-end target implies nearly 30% upside, while the low-end suggests potential downside of over 30%, underscoring the polarized views on the stock.

Sentiment has remained unchanged over the past month, with the rating distribution holding steady at 6 Strong Buys and 3 Holds. This stability suggests analysts are taking a wait-and-see approach heading into earnings rather than making significant revisions to their outlooks. The lack of recent upgrades or downgrades indicates the Street is reserving judgment until Q1 results provide clarity on whether Q4's disappointment was an anomaly or the start of a more concerning trend.

Part 4: Technical Picture

Credicorp's technical setup heading into earnings shows deteriorating momentum, with the stock trading at $317.68 — below all key short- and intermediate-term moving averages but maintaining support above the 200-day at $294.33. The Barchart Technical Opinion has weakened dramatically, declining from an 88% Buy signal one month ago to just 8% Buy currently, with last week registering 24% Buy — indicating a sharp and accelerating deterioration in technical conditions.

Timeframe Analysis:

• Short-term (50% Sell): Moderate sell signal indicates near-term momentum has turned negative, with the stock failing to hold recent support levels
• Medium-term (50% Buy): Neutral-to-positive reading suggests the intermediate trend remains constructive despite recent weakness, providing some technical cushion
• Long-term (50% Buy): Moderate buy signal reflects the stock's position above the 200-day moving average, indicating the longer-term uptrend remains intact

Trend Characteristics: The Weak strength combined with a Weakening direction suggests the technical environment is fragile heading into earnings, with momentum fading and the stock vulnerable to further downside if results disappoint.

The stock is trading below its 5-day ($323.24), 10-day ($322.73), 20-day ($325.44), 50-day ($331.38), and 100-day ($329.98) moving averages, indicating consistent selling pressure across all recent timeframes. The only technical support comes from the 200-day moving average at $294.33, which sits roughly 7.9% below current levels and could serve as a downside target if earnings trigger a negative reaction. The clustering of shorter-term moving averages in the $322–$331 range creates a resistance zone that the stock will need to reclaim to signal a technical reversal, making Thursday's earnings a critical inflection point for the chart.

Key resistance now sits at the 50-day moving average of $331.38, which aligns closely with the options market's upper expected move boundary of $331.41 — suggesting a beat-and-raise scenario would need to be compelling to break through this technical ceiling. On the downside, the 200-day moving average at $294.33 represents the critical support level that has defined the long-term uptrend. The overall technical setup is cautionary heading into earnings, with weakening momentum, deteriorating breadth signals, and the stock positioned below all meaningful short-term resistance levels — leaving little technical cushion if results fail to impress.